Navigation Links
MedX Health Receives CE Mark for Laser & Light Products
Date:3/4/2009

MedX Expects Accelerated Revenue Growth From World's Largest Economy

MISSISSAUGA, ON, March 4 /PRNewswire-FirstCall/ - MedX Health Corp., (TSXV.MDX) a global leader in developing drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced that the company has received CE Mark approval to market and sell the family of MedX laser and light products in all 25 European Union (EU) and three European Free Trade Association Member (EFTA) states. The CE Mark certifies that the MedX laser and light products have met EU health, safety and environmental requirements that ensure consumer and workplace safety.

"The CE Mark approval allows MedX to establish its global presence beyond North America, and further validates the benefits delivered through our non-invasive, drug-free products," states Steve Guillen, president and CEO of MedX Health. "This announcement comes shortly after achieving the International Organization of Standardization (ISO) re-certification, demonstrating to outside regulatory bodies that the highest quality standards are in place at MedX."

MedX continues to build upon its 10+ years of success in North America of bringing symptom relief in a non-pharmacologic manner to the rehabilitation/chiropractic/sports medicine markets. Through a rapidly growing international distributor network, which now includes the European Union, one of the largest and fastest growing markets in the world, MedX intends to expand its global reach and increase its revenue stream. Strong patent protection as well as developing and commercializing advanced products in the dental and wound care markets will also help position the company to increase revenues around the world. MedX presently holds key patents on its technology, and has received FDA clearance, Health Canada, and now the CE Mark on the family of laser and light products.

About MedX

MedX Health is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technology for use in numerous medical settings that provide patients with non-invasive, drug-free solutions for improving clinical outcomes. MedX's innovative Laser/Light Therapy devices enhance the patient's quality of life and improve the standard of care for tissue repair and pain relief.

MedX is expanding its distribution network and marketing programs globally through strategic partnerships, while continuing to develop and acquire new dental, rehabilitation and wound care products. In particular, MedX plans to accelerate the development of a new product aimed at the rapidly-growing wound care market. Recently, MedX announced a new patent allowance for bone growth that will join several key existing patents, including "Photobandage" a new technology that allows a wound to be bathed in light and is designed to enhance the healing process. The Company intends to license its proprietary wound care technologies to one or more major wound care companies for further development, marketing and commercialization.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information may include statements regarding the Company's future plans, objectives, performance, growth, profits, operating expenses or its underlying assumptions. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedX to be materially different from those expressed or implied by such forward-looking information, including uncertainty of successful development of new products, uncertainty of successful manufacturing or marketing of products, uncertainty of commercial acceptance of products, uncertainty concerning governmental regulation, dependency on key employees and relationships, rapid technological changes, foreign currency fluctuations. MedX does not undertake to update any forward-looking information, except in accordance with applicable securities laws.


'/>"/>
SOURCE MedX Health Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shape Partners With Iams to Create Healthy Living Program Walk Your Dog, Make Life Better
2. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
3. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
4. Health Strategies & Solutions Diagnoses Trends and Implications for Healthcare Industry in 2009 and Beyond
5. BioMarin to Present at the Barclays Capital Global Healthcare Conference
6. AFGE Congratulates Health and Human Services Secretary-designate Kathleen Sebelius
7. Lifeclinic International to Acquire Controlling Interest in My Health Rewards
8. Health Integrated Enjoys Steady Growth
9. Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers
10. Career Step Launches New Training Program for Careers in Secure Healthcare Industry
11. HealthYes! Now Offering its Preventive Health Screening Services in Houston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... the largest manufacturer of oats in China, is now aiming at global business expansion, ... globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, strongly recommends ... sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice are the ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... Santa Rosa, CA (PRWEB) , ... January 21, ... ... announce the opening of its new medical office in Petaluma, located at 167 ... full-service casting room, access to SRO sports medicine and rehabilitation services ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental implant ... media for its creos™ line of bone regenerative products. Specifically, the ... he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: